Please Wait.....
Report
APAC Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2023-02-01 I 262 Pages I Data Bridge Market Research
Asia-Pacific gastric cancer diagnostics market is projected to register a CAGR of 10.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Asia-Pacific Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric, and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor (GIST), Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country ( Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast To 2030
Some of the major factors contributing to the growth of the Asia-Pacific gastric cancer diagnostics market are:
- Rising healthcare expenditure for better health services
- Increase in diagnostic procedures for gastric cancer
- Growing prevalence of gastric cancer
Market Players:
Some of the key market players in the Asia-Pacific gastric cancer diagnostics market are listed below:
- BIOMERIEUX
- Myriad Genetics, Inc.
- ACON Laboratories, Inc.
- Vela Diagnostics
- Abbott
- AdvaCare Pharma
- MiRXES
- Fujirebio ( An H.U. Group company)
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- GENERAL ELECTRIC COMPANY
- Agilent Technologies, Inc.
- Endofotonics Pte Ltd
- Biohit Oyj
- DiaSorin S.p.A
- Paragon Genomics, Inc.
- QIAGEN
TABLE OF CONTENTS
1 INTRODUCTION 47
1.1 OBJECTIVES OF THE STUDY 47
1.2 MARKET DEFINITION 47
1.3 OVERVIEW OF THE ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET 47
1.4 LIMITATIONS 50
1.5 MARKETS COVERED 50
2 MARKET SEGMENTATION 53
2.1 MARKETS COVERED 53
2.2 GEOGRAPHICAL SCOPE 54
2.3 YEARS CONSIDERED FOR THE STUDY 55
2.4 CURRENCY AND PRICING 55
2.5 DBMR TRIPOD DATA VALIDATION MODEL 56
2.6 MULTIVARIATE MODELLING 59
2.7 PRODUCT TYPE LIFELINE CURVE 59
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 60
2.9 DBMR MARKET POSITION GRID 61
2.10 VENDOR SHARE ANALYSIS 62
2.11 MARKET END COVERAGE GRID 63
2.12 SECONDARY SOURCES 64
2.13 ASSUMPTIONS 64
3 EXECUTIVE SUMMARY 65
4 PREMIUM INSIGHT 68
4.1 PESTEL'S MODEL 69
4.2 PORTER'S 5 FORCES 70
4.3 EPIDEMIOLOGY 71
4.4 BRAND ANALYSIS 72
4.5 ROLE OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML): ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET 76
4.6 INDUSTRY INSIGHTS: 78
5 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, REGULATORY 79
5.1 ASIA-PACIFIC 79
5.1.1 REGULATORY SCENARIO IN AUSTRALIA- 79
5.1.2 REGULATORY SCENARIO IN JAPAN 79
5.1.3 REGULATORY SCENARIO IN CHINA 79
5.1.4 REGULATORY SCENARIO IN SINGAPORE- 80
6 MARKET OVERVIEW 82
6.1 DRIVERS 84
6.1.1 INCREASE IN INCIDENCE OF GASTROINTESTINAL TUMOURS, LYMPHOMA, AND ADENOCARCINOMA 84
6.1.2 RISE IN ALCOHOL CONSUMPTION AND SURGE IN SMOKING 84
6.1.3 INCREASE IN THE GERIATRIC POPULATION 85
6.1.4 RECENT ADVANCEMENTS IN GASTRIC CANCER DIAGNOSTICS PRODUCTS 85
6.2 RESTRAINTS 86
6.2.1 HIGH COST OF GASTRIC CANCER DIAGNOSTIC TEST 86
6.2.2 LACK OF SUFFICIENT FINANCIAL SUPPORT FROM HEALTH INSURANCE POLICIES 86
6.3 OPPORTUNITIES 87
6.3.1 RISE IN THE ADOPTION OF AUTOMATED SYSTEMS 87
6.3.2 INCREASED RESEARCH AND DEVELOPMENT ON CANCER DIAGNOSTICS PRODUCTS 87
6.3.3 STRATEGIC INITIATIVES BY EMERGING PLAYERS 88
6.4 CHALLENGES 89
6.4.1 STRINGENT REGULATIONS AND POLICIES FOR APPROVING THE COMPLICATED NATURE OF RADIATION DEVICES 89
6.4.2 LIMITATIONS OF RADIATION TESTS 89
7 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 90
7.1 OVERVIEW 91
7.2 REAGENTS & CONSUMABLES 94
7.2.1 KITS 95
7.2.1.1 DNA POLYMERASE KITS 95
7.2.1.2 PCR KITS 95
7.2.1.3 NUCLEIC ACID ISOLATION KITS 95
7.2.1.4 OTHERS 95
7.2.2 REAGENTS 96
7.2.2.1 ASSAYS 96
7.2.2.2 BUFFERS 96
7.2.2.3 PRIMERS 96
7.2.2.4 OTHERS 96
7.3 INSTRUMENTS 97
7.4 SERVICES 98
8 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE 99
8.1 OVERVIEW 100
8.2 CONFIRMATORY TEST 103
8.2.1 IMAGING TESTS 104
8.2.1.1 PET SCAN/CT SCAN 104
8.2.1.2 CT SCAN 104
8.2.1.3 ULTRASOUND 104
8.2.1.4 MRI 105
8.2.1.5 X-RAY 105
8.2.2 BIOMARKER 105
8.2.2.1 DNA BIOMARKER 105
8.2.2.2 RNA BIOMARKER 105
8.2.2.3 PROTEIN BIOMARKER 105
8.2.3 BIOPSY 105
8.3 GASTRIC CANCER SCREENING TESTS/PHYSICAL EXAM 106
9 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP 107
9.1 OVERVIEW 108
9.2 GERIATRICS 111
9.3 ADULT 112
9.4 PEDIATRIC 113
10 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE 114
10.1 OVERVIEW 115
10.2 INTESTINAL OR DIFFUSE ADENOCARCINOMA 118
10.3 CARCINOID TUMOR 119
10.4 GASTROINTESTINAL STROMAL TUMOR 120
10.5 GASTRIC LYMPHOMA 121
10.6 OTHERS 122
11 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE 123
11.1 OVERVIEW 124
11.2 STAGE I 127
11.2.1 STAGE IA 128
11.2.2 STAGE IB 128
11.3 STAGE II 128
11.3.1 STAGE IIA 129
11.3.2 STAGE IIB 129
11.4 STAGE III 129
11.4.1 STAGE IIIA 130
11.4.2 STAGE IIIB 131
11.4.3 STAGE IIIC 131
11.5 STAGE 0 131
12 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER 132
12.1 OVERVIEW 133
12.2 MALE 136
12.3 FEMALE 137
13 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE 138
13.1 OVERVIEW 139
13.2 STOOL 142
13.3 TISSUE 143
13.4 BLOOD 144
13.5 URINE 145
14 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER 146
14.1 OVERVIEW 147
14.2 HOSPITALS 150
14.3 DIAGNOSTIC LABORATORIES 151
14.4 CANCER RESEARCH INSTITUTES 152
14.5 ONCOLOGY SPECIALTY CLINICS 153
14.6 OTHERS 154
15 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 155
15.1 OVERVIEW 156
15.2 DIRECT TENDERS 159
15.3 RETAIL SALES 160
16 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION 161
16.1 ASIA-PACIFIC 162
16.1.1 SOUTH KOREA 172
16.1.2 JAPAN 177
16.1.3 CHINA 182
16.1.4 AUSTRALIA 187
16.1.5 SINGAPORE 192
16.1.6 INDIA 197
16.1.7 THAILAND 202
16.1.8 MALAYSIA 207
16.1.9 INDONESIA 212
16.1.10 PHILIPPINES 217
16.1.11 REST OF ASIA-PACIFIC 222
17 ASIA PACIFIC GASTRIC CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 223
17.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 223
18 SWOT ANALYSIS 224
19 COMPANY PROFILE 225
19.1 F. HOFFMANN-LA ROCHE LTD 225
19.1.1 COMPANY SNAPSHOT 225
19.1.2 REVENUE ANALYSIS 225
19.1.3 COMPANY SHARE ANALYSIS 226
19.1.4 PRODUCT PORTFOLIO 226
19.1.5 RECENT DEVELOPMENT 226
19.2 GENERAL ELECTRIC 227
19.2.1 COMPANY SNAPSHOT 227
19.2.2 REVENUE ANALYSIS 227
19.2.3 COMPANY SHARE ANALYSIS 228
19.2.4 PRODUCT PORTFOLIO 228
19.2.5 RECENT DEVELOPMENT 228
19.3 ABBOTT 229
19.3.1 COMPANY SNAPSHOT 229
19.3.2 REVENUE ANALYSIS 229
19.3.3 COMPANY SHARE ANALYSIS 230
19.3.4 PRODUCT PORTFOLIO 230
19.3.5 RECENT DEVELOPMENT 230
19.4 QIAGEN 231
19.4.1 COMPANY SNAPSHOT 231
19.4.2 REVENUE ANALYSIS 231
19.4.3 COMPANY SHARE ANALYSIS 232
19.4.4 PRODUCT PORTFOLIO 232
19.4.5 RECENT DEVELOPMENT 232
19.5 MYRIAD GENETICS, INC. 233
19.5.1 COMPANY SNAPSHOT 233
19.5.2 REVENUE ANALYSIS 233
19.5.3 COMPANY SHARE ANALYSIS 234
19.5.4 PRODUCT PORTFOLIO 234
19.5.5 RECENT DEVELOPMENT 234
19.6 ACON LABORATORIES, INC. 235
19.6.1 COMPANY SNAPSHOT 235
19.6.2 PRODUCT PORTFOLIO 235
19.6.3 RECENT DEVELOPMENT 235
19.7 ADVACARE PHARMA 236
19.7.1 COMPANY SNAPSHOT 236
19.7.2 PRODUCT PORTFOLIO 236
19.7.3 RECENT DEVELOPMENT 236
19.8 AGILENT TECHNOLOGIES, INC. 237
19.8.1 COMPANY SNAPSHOT 237
19.8.2 REVENUE ANALYSIS 237
19.8.3 PRODUCT PORTFOLIO 238
19.8.4 RECENT DEVELOPMENTS 238
19.9 BIOMERIEUX 239
19.9.1 COMPANY SNAPSHOT 239
19.9.2 REVENUE ANALYSIS 239
19.9.3 PRODUCT PORTFOLIO 240
19.9.4 RECENT DEVELOPMENT 240
19.10 BIOCEPT, INC. 241
19.10.1 COMPANY SNAPSHOT 241
19.10.2 REVENUE ANALYSIS 241
19.10.3 PRODUCT PORTFOLIO 242
19.10.4 RECENT DEVELOPMENT 242
19.11 BIOHIT OYJ 243
19.11.1 COMPANY SNAPSHOT 243
19.11.2 REVENUE ANALYSIS 243
19.11.3 PRODUCT PORTFOLIO 244
19.11.4 RECENT DEVELOPMENT 244
19.12 DIASORIN S.P.A 245
19.12.1 COMPANY SNAPSHOT 245
19.12.2 REVENUE ANALYSIS 245
19.12.3 PRODUCT PORTFOLIO 246
19.12.4 RECENT DEVELOPMENT 246
19.13 ENDOFOTONICS PTE LTD 247
19.13.1 COMPANY SNAPSHOT 247
19.13.2 PRODUCT PORTFOLIO 247
19.13.3 RECENT DEVELOPMENT 247
19.14 FOUNDATION MEDICINE, INC. 248
19.14.1 COMPANY SNAPSHOT 248
19.14.2 PRODUCT PORTFOLIO 248
19.14.3 RECENT DEVELOPMENTS 248
19.15 FUJIREBIO (AN H.U. GROUP COMPANY) 249
19.15.1 COMPANY SNAPSHOT 249
19.15.2 REVENUE ANALYSIS 249
19.15.3 PRODUCT PORTFOLIO 250
19.15.4 RECENT DEVELOPMENT 250
19.16 MIRXES PTE LTD. 251
19.16.1 COMPANY SNAPSHOT 251
19.16.2 PRODUCT PORTFOLIO 251
19.16.3 RECENT DEVELOPMENT 251
19.17 PARAGON GENOMICS, INC. 252
19.17.1 COMPANY SNAPSHOT 252
19.17.2 PRODUCT PORTFOLIO 252
19.17.3 RECENT DEVELOPMENTS 252
19.18 TECO DIAGNOSTICS 253
19.18.1 COMPANY SNAPSHOT 253
19.18.2 PRODUCT PORTFOLIO 253
19.18.3 RECENT DEVELOPMENT 253
19.19 THERMO FISHER SCIENTIFIC INC. 254
19.19.1 COMPANY SNAPSHOT 254
19.19.2 REVENUE ANALYSIS 254
19.19.3 PRODUCT PORTFOLIO 255
19.19.4 RECENT DEVELOPMENTS 255
19.20 VELA DIAGNOSTICS 256
19.20.1 COMPANY SNAPSHOT 256
19.20.2 PRODUCT PORTFOLIO 256
19.20.3 RECENT DEVELOPMENTS 256
20 QUESTIONNAIRE 257
21 RELATED REPORTS 262
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security